Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Withdrawn NCT04800107

Effect of Highly Bioavailable Curcumin on Subjective Tinnitus

Conditions: Tinnitus, Subjective

Sex: All
Ages: 18 Years – 99 Years
Healthy volunteers: No
Phase: NA
Sponsor: Henry Ford Health System

Location: Michigan Ear Institute Farmington Hills Michigan

Summary

This study will assess the effectiveness of highly bioavailable curcumin in suppressing subjective tinnitus based on pre- and post-treatment evaluations using the validated Tinnitus Functional Index (TFI) and Tinnitus Handicap Inventory (THI) surveys.

Eligibility Criteria

Inclusion Criteria: * Adults with subjective tinnitus due to sensorineural hearing loss as determined by routine audiogram. Exclusion Criteria: * Adults with subjective tinnitus due to another cause * Sensitivity or allergy to test compounds * Use of other off-label medications, substances, treatments specifically for tinnitus mitigation (e.g., anti-depressant/anxiety medications, GABA-inhibitors, psychiatric-based interventions/counseling) * Pregnancy * Patients taking anticoagulants to minimize risk of drug-drug interactions.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04800107). StuddyBuddy aggregates publicly available trial information.